FDA EIR - David Hassman, DO - July 13, 2004

This document summarizes an FDA inspection conducted at David Hassman, DO, in Berlin, NJ 08009, between June 30, 2004, and July 13, 2004. The outcome of this inspection is an FDA Form 483, an official report issued when investigators observe conditions or practices that may indicate potential deviations from federal regulatory requirements, particularly those outlined in the Food, Drug, and Cosmetic Act. Due to extensive redactions, marked under (b)(4) and (b)(6) exemptions, the specific findings, main violations, or issues observed during this inspection are not detailed within the provided content. Consequently, the precise nature of any non-compliance or the areas requiring improvement cannot be identified. In response to an FDA Form 483, companies are typically expected to provide a comprehensive written response to the agency. This response should outline the corrective actions implemented or planned to address each observation to ensure future adherence to regulatory standards. However, given the heavily redacted nature of this report, the specific required actions for David Hassman, DO, cannot be determined from this document.